BioAge Labs - About the company
BioAge Labs is a public company based in Emeryville (United States), founded by Kristen Fortney. It operates as a Provider of a bioinformatics platform for biomarkers and drug discovery. BioAge Labs has raised $294M in funding from investors like Andreessen Horowitz, Felicis Ventures and Sofinnova Investments. The company has 214 active competitors, including 74 funded and 54 that have exited. Its top competitors include companies like Biogen, Rhythm Pharmaceuticals and MannKind Corp.
Company Details
BioAge develops a bioinformatics platform for biomarkers and drug discovery. The platform is focused on applying computational biology techniques for the identification of genomic biomarkers for the discovery of new medicines using AI technology.
- Website
- bioagelabs.com
- Social
- Email ID
- *****@bioagelabs.com
- Phone Number
- +1 **********
- Registered Address
- Berkeley, California
Key Metrics
Location
Emeryville, United States
Stage
Public
Total Funding
$294M in 4 rounds
Latest Funding Round
Investors
Ranked
15th among 214 active competitors
Annual Revenue
$1M - $10M as on Dec 31, 2025
Employee Count
100 as on Jun 30, 2026
Exit Details
Public
Legal entities associated with BioAge Labs
BioAge Labs is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
BIOAGE LABS CIN: 474721157 , United States, Active | Dec 26, 999 | - | 64 (As on Dec 31, 2024) | - |
Bioage Labs, Inc. CIN: 5721379 , United States, Active | Mar 31, 2015 | $1M - $10M (As on Dec 31, 2025) | 40 (As on Dec 31, 2020) | - |
BioAge Labs's IPO details
BioAge Labs got listed on Sep 26, 2024.
Click here to take a look at BioAge Labs's IPO in detail
Sign up to download BioAge Labs' company profile
BioAge Labs's funding and investors
BioAge Labs has raised a total funding of $294M over 4 rounds. Its first funding round was on Jul 28, 2017. Its latest funding round was a Series D round on Feb 13, 2024 for $*****. 13 investors participated in its latest round. BioAge Labs has 26 institutional investors and 2 angel investors.
Here is the list of recent funding rounds of BioAge Labs:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Feb 13, 2024 | 7229936 | Series D | 6756634 | 6838384 | 1372754 | 6715265 |
Dec 03, 2020 | 6687103 | Series C | 3269359 | 9188534 | 4150958 | |
Jan 24, 2019 | 5548560 | Series B | 7453925 | 1396100 |
Access funding benchmarks and valuations. Sign up today!View details of BioAge Labs's funding rounds and investors
BioAge Labs' founders and board of directors
Founder? Claim ProfileThe founders of BioAge Labs is Kristen Fortney.
Here are the details of BioAge Labs' key team members:
- Kristen Fortney: Co-Founder & CEO of BioAge Labs. They are also an angel investor in 2 startups.Contact Info: 1 email address
View details of BioAge Labs's Founder profiles and Board Members
BioAge Labs' employee count trend
BioAge Labs has 100 employees as of Jun 26. Here is BioAge Labs's employee count trend over the years:
Uncover BioAge Labs' growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
BioAge Labs's Competitors and alternates
Top competitors of BioAge Labs include Biogen, Rhythm Pharmaceuticals and MannKind Corp. Here is the list of Top 10 competitors of BioAge Labs, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Biogen 1978, Cambridge (United States), Public | Developer of therapies for neurodegenerative and immunology disorders | $80M | 78/100 | |
2nd | Rhythm Pharmaceuticals 2010, Boston (United States), Public | Developer of peptide therapeutics for the treatment of rare genetic deficiencies | $84M | 70/100 | |
3rd | MannKind Corp 1991, Los Angeles (United States), Public | Developer of small-molecule drugs | $50M | 70/100 | |
4th | Developer of therapeutics for the treatment of diabetes and obesity | $26M | 69/100 | ||
5th |  AskBio 2001, Durham (United States), Acquired | Developer of AAV technologies for treating genetic and complex disorders | $235M | 68/100 | |
6th | Corcept 1998, Menlo Park (United States), Public | Developer of cortisol modulators for the treatment of various diseases | - | 68/100 | |
7th | Cytokinetics 1997, San Francisco (United States), Public | Developer of muscle activators as potential treatments for debilitating diseases | $60M | 68/100 | |
8th | Regenxbio 2008, Rockville (United States), Public | Developer of AAV Gene Therapy for rare genetic diseases | $108M | 67/100 | |
9th | Tonix Pharma 2007, New York City (United States), Public | Developer of next-generation medicines for CNS and immunological disorders | $4.45M | 66/100 | |
10th | MeiraGTx 2015, New York City (United States), Public | Developer of gene therapies for ocular and neurodegenerative diseases | - | 65/100 | |
15th |  BioAge Labs Emeryville (United States), Public | Provider of a bioinformatics platform for biomarkers and drug discovery | $294M | 62/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on BioAge Labs's competitors? Click here to see the top ones
BioAge Labs's Investments and acquisitions
BioAge Labs has made no investments or acquisitions yet.
Reports related to BioAge Labs
Here is the latest report on BioAge Labs's geography:
News related to BioAge Labs
Filter this listMedia has covered BioAge Labs for a total of 14 events in the last 1 year, 11 of them have been about company updates.
•
•
BioAge Labs Reports First Quarter 2026 Financial Results and Provides Business UpdatesGlobeNewswire•May 08, 2026•BioAge Labs
•
BioAge Labs Stock Gains After Positive Early Data And Pipeline PlansBenzinga•Apr 21, 2026•BioAge Labs
•
BioAge Labs Reports FY 2025 Financial Results, Business UpdatesGlobeNewswire•Mar 24, 2026•BioAge Labs
•
Certain Common Stock of BioAge Labs, Inc. are subject to a LockStock Screener•Mar 23, 2026•BioAge Labs
•
•
•
•
•
BioAge Labs Reports Third Quarter 2025 Financial Results and Provides Business UpdatesGlobeNewswire•Nov 07, 2025•BioAge Labs
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about BioAge Labs
Explore our recently published companies
- Caffeina - Parma based, 2012 founded, Funding Raised company
- Global Automotive - Kosovo based, 2012 founded, Unfunded company
- Leica Rumors - 2008 founded, Unfunded company
- Bake Or Break - 2006 founded, Unfunded company
- Martinez Landscaping - United States based, 1989 founded, Unfunded company
- Peak Asphalt - United States based, 1997 founded, Unfunded company
